The Safety and Efficacy of Bacillus Calmette-Guerin Intravesical Therapy in Kidney Transplant Recipients with Superficial Bladder Cancer.

Bladder cancer is frequently encountered in kidney-recipients and its treatment can be challenging. In fact, it is not known whether adjuvant intravesical Bacillus Calmette-Guerin (BCG) instillation may be as effective and safe as in non-immunosuppressed patient. In this letter, we reported results from all studies available to date on BCG treatment in kidney recipients, to discuss safety and efficacy of this treatment modality, in this special population with an altered immune response.